Cargando…
Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177786/ https://www.ncbi.nlm.nih.gov/pubmed/21871123 http://dx.doi.org/10.1186/1756-3305-4-168 |
_version_ | 1782212326977437696 |
---|---|
author | Zou, Jun Huang, Xiao-Xi Yin, Guang-Wen Ding, Ye Liu, Xian-Yong Wang, Heng Chen, Qi-Jun Suo, Xun |
author_facet | Zou, Jun Huang, Xiao-Xi Yin, Guang-Wen Ding, Ye Liu, Xian-Yong Wang, Heng Chen, Qi-Jun Suo, Xun |
author_sort | Zou, Jun |
collection | PubMed |
description | BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH strain was engineered to express the yellow fluorescent protein (YFP) in the cytoplasm. A subcutaneous injection of the transgenic T. gondii YFP in chickens afforded partial protection against the infection of transgenic E. tenella YFP. T. gondii YFP induced low levels of antibodies to YFP in chickens, suggesting that YFP specific cellular immune response was probably responsible for the protective immunity against E. tenella YFP infection. The measurement of T-cell response and IFN-γ production further confirmed that YFP specific Th1 mediated immune response was induced by T. gondii YFP in immunized chickens. The transgenic T. gondii stimulated significantly higher YFP specific IgG titers in rabbits than in chickens, suggesting greater immunogenicity in a T. gondii susceptible species than in a resistant species. Priming with T. gondii YFP and boosting with the recombinant YFP can induce a strong anti-YFP antibody response in both animal species. CONCLUSIONS: Our findings suggest that T. gondii can be used as an effective vaccine vector and future research should focus on exploring avirulent no cyst-forming strains of T. gondii as a live vaccine vector in animals. |
format | Online Article Text |
id | pubmed-3177786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31777862011-09-22 Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts Zou, Jun Huang, Xiao-Xi Yin, Guang-Wen Ding, Ye Liu, Xian-Yong Wang, Heng Chen, Qi-Jun Suo, Xun Parasit Vectors Research BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH strain was engineered to express the yellow fluorescent protein (YFP) in the cytoplasm. A subcutaneous injection of the transgenic T. gondii YFP in chickens afforded partial protection against the infection of transgenic E. tenella YFP. T. gondii YFP induced low levels of antibodies to YFP in chickens, suggesting that YFP specific cellular immune response was probably responsible for the protective immunity against E. tenella YFP infection. The measurement of T-cell response and IFN-γ production further confirmed that YFP specific Th1 mediated immune response was induced by T. gondii YFP in immunized chickens. The transgenic T. gondii stimulated significantly higher YFP specific IgG titers in rabbits than in chickens, suggesting greater immunogenicity in a T. gondii susceptible species than in a resistant species. Priming with T. gondii YFP and boosting with the recombinant YFP can induce a strong anti-YFP antibody response in both animal species. CONCLUSIONS: Our findings suggest that T. gondii can be used as an effective vaccine vector and future research should focus on exploring avirulent no cyst-forming strains of T. gondii as a live vaccine vector in animals. BioMed Central 2011-08-28 /pmc/articles/PMC3177786/ /pubmed/21871123 http://dx.doi.org/10.1186/1756-3305-4-168 Text en Copyright ©2011 Zou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Zou, Jun Huang, Xiao-Xi Yin, Guang-Wen Ding, Ye Liu, Xian-Yong Wang, Heng Chen, Qi-Jun Suo, Xun Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title | Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title_full | Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title_fullStr | Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title_full_unstemmed | Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title_short | Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
title_sort | evaluation of toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177786/ https://www.ncbi.nlm.nih.gov/pubmed/21871123 http://dx.doi.org/10.1186/1756-3305-4-168 |
work_keys_str_mv | AT zoujun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT huangxiaoxi evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT yinguangwen evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT dingye evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT liuxianyong evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT wangheng evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT chenqijun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts AT suoxun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts |